MLAB News & Events

Reports Q1 revenue $63.72M, consensus $65.2M. "As announced in March, I am in the middle of my onboarding journey as I am conducting my first 100 days review of the businesses since joining Mesa on April 13. I want to share that I am even more excited today than the day I joined. The Mesa diversified platform has tremendous potential to create shareholder value while delivering on our promise to Protect the Vulnerable. Upon completion of my 100-day review of our business, I am looking forward to begin meeting with our shareholders and discussing my vision for the Company moving forward. I also expect to be in position to provide rest of the year guidance along with the release of H1 results," said Siddhartha Kadia, president and CEO of Mesa.

Mesa Labs announced that Gary Owens will step down as president and CEO on April 12 and will enable a leadership transition. To lead the company's next chapter, the board of directors has appointed Siddhartha Kadia as president and CEO, effective April 13. Kadia will also join the board. Kadia most recently served as CEO of Calibre Scientific.

Reports Q3 revenue $65.126M, consensus $63.23M. "Steady execution and relatively stable markets across Europe and North America helped deliver 3.6% organic revenues growth in 3Q26 versus the prior year, or 5.7% when excluding CG China revenues. Total company growth was 7.2% sequentially, well within our expected growth range. Strong growth in BPD, continued growth in CG excluding China, and a recovery towards normal SDC deliveries overcame strong but expected headwinds in CG China. For the first nine months of FY26, we delivered 3.7% organic revenues growth, but 6.6% when excluding CG China revenues. With continued strong execution across the business and less impactful CG China compares moving forward, we expect our positive momentum to continue in 4Q26" said Gary Owens, Chief Executive Officer of Mesa.